Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02480803 : INfusion VErsus STimulation in Parkinson's Disease
PhasePhase 4
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Idiopathic Parkinson's Disease with bradykinesia and at least two of the following
signs; resting tremor, rigidity, and asymmetry;

- Despite optimal pharmacological treatment, at least one of the following symptoms:
severe response fluctuations, dyskinesias, painful dystonia or bradykinesia;

- A life expectancy of at least two years.

Exclusion Criteria:

- Age below 18 years

- Previous PD-neurosurgery (e.g., DBS, pallidotomy, thalamotomy);

- Previous CLI (through a PEG-tube or Nasal Jejuna| tube);

- Hoehn and Yahr stage 5 at the best moment during the day;

- Other severely disabling disease;

- Dementia or signs of severe cognitive impairment

- Psychosis;

- Current depression;

- Contraindications for DBS surgery, such as a physical disorder making surgery
hazardous;

- Contraindications for PEG surgery such as interposed organs, ascites and
oesophagogastric varices, or for Duodopa;

- Pregnancy, breastfeeding, and women of child bearing age not using a reliable method
of contraception;

- No informed consent;

- Legally incompetent adults;
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02480803      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740